[Reuters] - The U.S. Supreme Court said on Monday it would leave intact a $142 million jury verdict against Pfizer Inc over its marketing of the epilepsy drug...(read more
[optionMONSTER] - Zoetis was spun off from Pfizer early this year, and one big investor thinks the animal spirits are ready to take over. optionMONSTER's Heat Seeker monitoring program...(read more
Pfizer Inc. (PFE) recently faced a pipeline setback with the company discontinuing a late-stage study being conducted with its oncology candidate, inotuzumab ozogamicin.
The randomized,...(read more